Marshall Wace, LLP Cytokinetics Inc Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Cytokinetics Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 1,873,701 shares of CYTK stock, worth $91.8 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,873,701

Previous 1,678,159 11.65%

Holding current value

$91.8 Million

Previous $90.9 Million 8.81%

% of portfolio

0.13%

Previous 0.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $10 Million - $11.8 Million	195,542 Added 11.65%	1,873,701 $98.9 Million
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $42.1 Million - $65.9 Million	-878,644 Reduced 34.36%	1,678,159 $90.9 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $123 Million - $209 Million	1,930,716 Added 308.38%	2,556,803 $179 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $24.4 Million - $75.8 Million	-907,882 Reduced 59.19%	626,087 $52.3 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $37.7 Million - $46.8 Million	1,278,577 Added 500.63%	1,533,969 $45.2 Million
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $16 Million - $20 Million	-489,915 Reduced 65.73%	255,392 $8.33 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $8.88 Million - $12.2 Million	-266,155 Reduced 26.31%	745,307 $26.2 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $1.99 Million - $2.84 Million	55,576 Added 5.81%	1,011,462 $46.3 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $15.3 Million - $21.7 Million	-397,251 Reduced 29.36%	955,886 $46.3 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $44.9 Million - $64.7 Million	1,322,232 Added 4278.38%	1,353,137 $53.2 Million
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $394,530 - $610,236	-13,266 Reduced 30.03%	30,905 $1.14 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $3.03 Million - $4.1 Million	-88,326 Reduced 66.66%	44,171 $2.01 Million
Q2 2021 Aug 13, 2021	SELL	$19.79 - $26.99 $2.8 Million - $3.82 Million	-141,409 Reduced 51.63%	132,497 $2.62 Million
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $4.12 Million - $5.69 Million	221,628 Added 423.94%	273,906 $6.37 Million
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $2.37 Million - $4.44 Million	-155,175 Reduced 74.8%	52,278 $1.09 Million
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $4.27 Million - $6.01 Million	207,453 New	207,453 $4.49 Million
Q2 2019 Aug 14, 2019	SELL	$7.95 - $11.25 $63,568 - $89,955	-7,996 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.91 - $9.29 $47,256 - $74,282	7,996 New	7,996 $51,000
Q2 2018 Aug 14, 2018	SELL	$6.9 - $9.9 $211,140 - $302,940	-30,600 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$7.2 - $10.05 $220,320 - $307,530	30,600 New	30,600 $220,000

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.61B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Cytokinetics Inc Transaction History